Cannabis Use Makes Quitting Tobacco Harder, But CBD Might Help

Meta-analysis of 18 observational studies (N=229,630) found cannabis use was associated with 35% lower odds of quitting tobacco (OR=0.65). However, preclinical and early clinical evidence suggests CBD specifically may reduce cigarette consumption by 40%, reverse attentional bias to smoking cues, and alleviate withdrawal.

Translational systematic review and meta-analysis following PRISMA 2020 guidelines, searching multiple databases through January 2026. Included 52 studies across three categories: observational co-use studies, preclinical cannabinoid modulator studies, and human experimental ECS-intervention studies.

With 18-22% of tobacco users also using cannabis, understanding how co-use affects quit attempts is critical. The key distinction here is that casual cannabis use hurts cessation, but pharmacologically targeted CBD could actually help.

The failure of CB1 receptor antagonists (like rimonabant) due to depression and suicidality is a cautionary tale. CBD offers a potentially safer path to modulating the endocannabinoid system for smoking cessation, without the psychiatric risks.

High heterogeneity across observational studies (I-squared=88.1%). CBD clinical evidence is still early-stage. The distinction between naturalistic cannabis exposure and targeted CBD intervention is crucial but complicates interpretation.